Shine Medical Technologies has won a contract to provide molybdenum-99 (Mo-99) to Chinese radiopharmaceutical provider HTA.
Under terms of the deal, Shine will provide Mo-99 for use in HTA's technetium generators once Shine's facility becomes operational. Shine uses a proprietary low-enriched uranium technology to produce the isotope.
HTA is the largest producer and distributor of radiopharmaceuticals in China, Shine said. The agreement with Shine is its first with a U.S. supplier.
